Nothing could have been selected for translation before translation existed. So how did it start?
The answer is a merger, not an invention.
Two RNA systems, each complete and selected on its own terms — a peptide-bond ribozyme as generator, charged acceptor stems as carrier — brought together by co-compartmentalisation. The code is the frozen interface contract of that encounter. The constraint that forces this shape: any account must not select for translation before translation exists to be selected for.
The field's own words, and why they gate the answer
Stated by the field itself, from three directions and three decades: Crick 1968 — the origin of the ribosomal mechanism "presents grave difficulties"; Nissen et al. 2000 — the steps to messenger-directed synthesis "are not yet obvious"; Wolf & Koonin 2007 — the selective forces "remain obscure," an objection "perhaps even more prohibitive" than ribozyme imperfection.
That's the constraint the merger account is built to satisfy: the peptidyl-transferase centre (PTC) is a generator that condenses activated amino acids into untemplated peptide, selected on its own for that; charged acceptor stems are a carrier holding a stable link between one amino acid and one sequence, selected on its own for that. Neither needs translation to already exist. The CCA terminus is the interface where they meet, and the code is read as the record of where they met — chemistry biases the outcome without determining it.
Published as Translation is a merger, not an invention, DOI 10.5281/zenodo.22008798.
→ Someone has been near this. Who, and does it survive them?